← Search

Data · dataset · 2023

Supplementary files "Long-term effectiveness and safety of risankizumab for the treatment of plaque psoriasis in a real-life Italian multicenter cohort - IL PSO (ITALIAN LANDSCAPE PSORIASIS)"

Listed in Teesside University Research Data Repository

Supplementary Figure 1.

Description

Mean PASI trend during the study. PASI: Psoriasis Area and Severity Index.

Supplementary Figure 2. Effectiveness of risankizumab according to previous exposure to biological therapies. PASI: Psoriasis Area and Severity Index.

Read the rest (1 more)
  • p-value < 0.05; ** p-value ≤ 0.01; *** p-value ≤ 0.001 Supplementary Figure 3. Kaplan-Meier curve of all-cause treatment discontinuation in all patients treated with risankizumab up to 36 months. Supplementary Table 1. Mean PASI at each time-point according to all analyzed variables. PASI: Psoriasis Area and Severity Index. mPASI: mean PASI; PsA: Psoriatic Arthritis; CMD: Cardio-Metabolic Disease; BMI: Body Mass Index. Supplementary Table 2. Effectiveness of risankizumab according to the concomitant presence of PsA. PsA: Psoriatic Arthritis Supplementary Table 3. Effectiveness of risankizumab according to the presence of cardio-metabolic comorbidities and involvement of difficult-to-treat areas. PASI: Psoriasis Area and Severity Index; OR: Odds Ratio; CI: Confidence Interval; CMD: Cardio-Metabolic Disease; NA: Not Applicable (multivariate analysis was not performed for these variables, as the p-value at univariate analysis was ≥ 0.2); NS: Not Significant Supplementary Table 4. Effectiveness of risankizumab according to BMI classes. BMI: Body Mass Index; OR: Odds Ratio; CI: Confidence Interval; NA: Not Applicable (multivariate analysis was not performed for these variables, as the p-value at univariate analysis was ≥ 0.2); NS: Not Significant. ^ Obese versus normal-weight patients;
  • Obese versus overweight patients; ° Normal-weight versus overweight patients.

Links

Where it is published

Catalogue records · 1

Topics

From keywords
Dermatology · Earth & Environmental Science · Engineering · Humanities · Life Sciences · Social Science
Inferred from text
Disease 75% · Tabular 65%
Provenance · 1 source records, 13 field assertions
SourceKeyLast seenRaw
Teesside University Research Data Repositoryoai:data.mendeley.com/8g4y7gkjrf.211 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0
concepts[disease].local:disease:diseaseenrichment · researchdata tees ac ukkeyword-concept-rules@1.0.0title+description (75%)
concepts[field].anzsrc:field:320205mapping · researchdata tees ac ukvocabulary-mapper@1.0.0keywords['Dermatology']
concepts[field].local:field:earth-environmentalmapping · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0
concepts[field].local:field:engineeringmapping · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0
concepts[field].local:field:humanitiesmapping · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0
concepts[field].local:field:life-sciencesmapping · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0
concepts[field].local:field:social-sciencemapping · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0
concepts[modality].local:modality:tabularenrichment · researchdata tees ac ukkeyword-concept-rules@1.0.0title+description (65%)
descriptionsource · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0/metadata/dc/description
licensesource · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0/metadata/dc/rights
publication_datesource · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0
titlesource · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0/metadata/dc/title